NM_001370259.2:c.1621A>G

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001370259.2(MEN1):​c.1621A>G​(p.Thr541Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.97 in 1,613,650 control chromosomes in the GnomAD database, including 763,565 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.90 ( 62591 hom., cov: 33)
Exomes 𝑓: 0.98 ( 700974 hom. )

Consequence

MEN1
NM_001370259.2 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: 0.139
Variant links:
Genes affected
MEN1 (HGNC:7010): (menin 1) This gene encodes menin, a tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. Menin is a scaffold protein that functions in histone modification and epigenetic gene regulation. It is thought to regulate several pathways and processes by altering chromatin structure through the modification of histones. [provided by RefSeq, May 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in the MEN1 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 113 curated pathogenic missense variants (we use a threshold of 10). The gene has 20 curated benign missense variants. Trascript score misZ: 4.1921 (above the threshold of 3.09). GenCC associations: The gene is linked to multiple endocrine neoplasia type 1, pituitary gigantism, familial isolated hyperparathyroidism.
BP4
Computational evidence support a benign effect (MetaRNN=6.717767E-7).
BP6
Variant 11-64804546-T-C is Benign according to our data. Variant chr11-64804546-T-C is described in ClinVar as [Benign]. Clinvar id is 134640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-64804546-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.99 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MEN1NM_001370259.2 linkc.1621A>G p.Thr541Ala missense_variant Exon 10 of 10 ENST00000450708.7 NP_001357188.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEN1ENST00000450708.7 linkc.1621A>G p.Thr541Ala missense_variant Exon 10 of 10 5 NM_001370259.2 ENSP00000394933.3 O00255-2

Frequencies

GnomAD3 genomes
AF:
0.898
AC:
136517
AN:
152104
Hom.:
62559
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.713
Gnomad AMI
AF:
0.993
Gnomad AMR
AF:
0.903
Gnomad ASJ
AF:
0.997
Gnomad EAS
AF:
0.701
Gnomad SAS
AF:
0.986
Gnomad FIN
AF:
0.983
Gnomad MID
AF:
0.972
Gnomad NFE
AF:
0.996
Gnomad OTH
AF:
0.924
GnomAD3 exomes
AF:
0.937
AC:
235276
AN:
250986
Hom.:
111643
AF XY:
0.949
AC XY:
128788
AN XY:
135750
show subpopulations
Gnomad AFR exome
AF:
0.706
Gnomad AMR exome
AF:
0.881
Gnomad ASJ exome
AF:
0.996
Gnomad EAS exome
AF:
0.697
Gnomad SAS exome
AF:
0.995
Gnomad FIN exome
AF:
0.982
Gnomad NFE exome
AF:
0.996
Gnomad OTH exome
AF:
0.964
GnomAD4 exome
AF:
0.977
AC:
1428180
AN:
1461428
Hom.:
700974
Cov.:
69
AF XY:
0.979
AC XY:
712107
AN XY:
727040
show subpopulations
Gnomad4 AFR exome
AF:
0.700
Gnomad4 AMR exome
AF:
0.884
Gnomad4 ASJ exome
AF:
0.995
Gnomad4 EAS exome
AF:
0.733
Gnomad4 SAS exome
AF:
0.994
Gnomad4 FIN exome
AF:
0.982
Gnomad4 NFE exome
AF:
0.997
Gnomad4 OTH exome
AF:
0.959
GnomAD4 genome
AF:
0.897
AC:
136597
AN:
152222
Hom.:
62591
Cov.:
33
AF XY:
0.897
AC XY:
66721
AN XY:
74400
show subpopulations
Gnomad4 AFR
AF:
0.713
Gnomad4 AMR
AF:
0.903
Gnomad4 ASJ
AF:
0.997
Gnomad4 EAS
AF:
0.701
Gnomad4 SAS
AF:
0.986
Gnomad4 FIN
AF:
0.983
Gnomad4 NFE
AF:
0.996
Gnomad4 OTH
AF:
0.925
Alfa
AF:
0.969
Hom.:
60907
Bravo
AF:
0.881
TwinsUK
AF:
0.997
AC:
3696
ALSPAC
AF:
0.996
AC:
3839
ESP6500AA
AF:
0.738
AC:
3247
ESP6500EA
AF:
0.996
AC:
8559
ExAC
AF:
0.938
AC:
113841
Asia WGS
AF:
0.868
AC:
3022
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4Other:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 22, 2018
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 19, 2013
ITMI
Significance: not provided
Review Status: no classification provided
Collection Method: reference population

- -

Multiple endocrine neoplasia, type 1 Benign:4
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 23, 2018
Color Diagnostics, LLC DBA Color Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 03, 2024
All of Us Research Program, National Institutes of Health
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 05, 2024
Myriad Genetics, Inc.
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.047
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
1.6
DANN
Benign
0.54
DEOGEN2
Benign
0.22
T;.;.;.;.;T;T;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0060
N
LIST_S2
Benign
0.029
T;T;.;.;T;.;.;T;.
MetaRNN
Benign
6.7e-7
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.69
.;.;.;.;.;N;N;N;N
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-0.69
N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.87
T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.76
T;T;T;T;T;T;T;T;T
Polyphen
0.0
.;B;B;B;B;B;B;B;B
Vest4
0.053
MPC
1.0
ClinPred
0.0012
T
GERP RS
3.4
Varity_R
0.021
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2959656; hg19: chr11-64572018; COSMIC: COSV53639974; COSMIC: COSV53639974; API